ChromaDex Corporation is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
In the following press release company announced that, “A recent study led by Saioa Gomez-Zorita published in the Journal of Agricultural and Food Chemistry has demonstrated the weight loss effects of pterostilbene in rats fed an obesogenic diet.”
Chromadex Corp. engages in acquiring, developing, and commercializing proprietary-based ingredient technologies through its business model. It operates through the following segments: Ingredients, Core Standards and Contract Services, and Regulatory Consulting. The Ingredients segment offers to develop and commercialize proprietary-based ingredient technologies. The Core Standards and Contract Services segment involves focuses on natural product fine chemicals, chemistry, and analytical testing services. The Regulatory Consulting segment offers consulting projects for customers in Europe, South, America, and Asia. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Irvine, CA. [Source: MarketWatch]
Company Website: https://chromadex.com